Literature DB >> 32352641

EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells.

Ao Zhang1,2, Junji Xing2, Tianliang Xia1, Hua Zhang3, Mingli Fang2,4, Shibing Li1, Yong Du2, Xian C Li2,5, Zhiqiang Zhang2,5, Mu-Sheng Zeng1.   

Abstract

Inflammasomes are intracellular complexes that form in the cytosol of inflammatory cells. NLRP3 is one of the sensor proteins in the complex that can recognize a wide variety of stimuli ranging from microbial components to environmental particulates. Here, we report that in mouse airway epithelial cells (AECs), inflammasome activation is inhibited by EphA2, a member of the transmembrane tyrosine kinase receptor family, via tyrosine phosphorylation of NLRP3 in a model of reovirus infection. We find that EphA2 depletion markedly enhances interleukin-1β (IL-1β) and interleukin-18 (IL-18) production in response to the virus. EphA2-/- mice show stronger inflammatory infiltration and enhanced inflammasome activation upon viral infection, and aggravated asthma symptoms upon ovalbumin (ova) induction. Mechanistically, EphA2 binds to NLRP3 and induces its phosphorylation at Tyr132, thereby interfering with ASC speck formation and blocking the activation of the NLRP3-inflammasome. These data demonstrate that reovirus employs EphA2 to suppress inflammasome activation in AECs and that EphA2 deficiency causes a pathological exacerbation of asthma in an ova-induced asthma model.
© 2020 The Authors.

Entities:  

Keywords:  EphA2; NLRP3; asthma; inflammasome; reovirus

Mesh:

Substances:

Year:  2020        PMID: 32352641      PMCID: PMC7332978          DOI: 10.15252/embr.201949666

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  39 in total

Review 1.  NLRP3 at the interface of metabolism and inflammation.

Authors:  Moritz Haneklaus; Luke A J O'Neill
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 2.  Epithelial cells and airway diseases.

Authors:  David Proud; Richard Leigh
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

3.  NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation.

Authors:  Nan Song; Zhao-Shan Liu; Wen Xue; Zhao-Fang Bai; Qian-Yi Wang; Jiang Dai; Xin Liu; Yi-Jiao Huang; Hong Cai; Xiao-Yan Zhan; Qiu-Ying Han; Hongxia Wang; Yuan Chen; Hui-Yan Li; Ai-Ling Li; Xue-Min Zhang; Tao Zhou; Tao Li
Journal:  Mol Cell       Date:  2017-09-21       Impact factor: 17.970

4.  Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.

Authors:  Yiqing Yan; Wei Jiang; Lei Liu; Xiaqiong Wang; Chen Ding; Zhigang Tian; Rongbin Zhou
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

5.  EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability.

Authors:  Masamitsu Tanaka; Reiko Kamata; Ryuichi Sakai
Journal:  J Biol Chem       Date:  2005-10-18       Impact factor: 5.157

6.  T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes.

Authors:  Greta Guarda; Catherine Dostert; Francesco Staehli; Katrin Cabalzar; Rosa Castillo; Aubry Tardivel; Pascal Schneider; Jürg Tschopp
Journal:  Nature       Date:  2009-06-03       Impact factor: 49.962

7.  NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.

Authors:  Marianne R Spalinger; Stephanie Kasper; Claudia Gottier; Silvia Lang; Kirstin Atrott; Stephan R Vavricka; Sylvie Scharl; Tina Raselli; Isabelle Frey-Wagner; Petrus M Gutte; Markus G Grütter; Hans-Dietmar Beer; Emmanuel Contassot; Andrew C Chan; Xuezhi Dai; David J Rawlings; Florian Mair; Burkhard Becher; Werner Falk; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  J Clin Invest       Date:  2016-04-04       Impact factor: 14.808

Review 8.  New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease.

Authors:  Dominic De Nardo; Christine M De Nardo; Eicke Latz
Journal:  Am J Pathol       Date:  2013-10-30       Impact factor: 4.307

9.  EphA2 Receptor Signaling Mediates Inflammatory Responses in Lipopolysaccharide-Induced Lung Injury.

Authors:  Ji Young Hong; Mi Hwa Shin; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Moo Suk Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

10.  TRIM29 promotes DNA virus infections by inhibiting innate immune response.

Authors:  Junji Xing; Ao Zhang; Hua Zhang; Jin Wang; Xian Chang Li; Mu-Sheng Zeng; Zhiqiang Zhang
Journal:  Nat Commun       Date:  2017-10-16       Impact factor: 14.919

View more
  12 in total

1.  Hijacking the NLRP3 inflammasome: a mechanism underlying viral respiratory disease?

Authors:  Zhirong Zhang; Romeo Ricci
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

Review 2.  PHOrming the inflammasome: phosphorylation is a critical switch in inflammasome signalling.

Authors:  Chloe M McKee; Fabian A Fischer; Jelena S Bezbradica; Rebecca C Coll
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

3.  Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma.

Authors:  Ming Ma; Guoyang Li; Minghui Qi; Wei Jiang; Rongbin Zhou
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

4.  EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells.

Authors:  Ao Zhang; Junji Xing; Tianliang Xia; Hua Zhang; Mingli Fang; Shibing Li; Yong Du; Xian C Li; Zhiqiang Zhang; Mu-Sheng Zeng
Journal:  EMBO Rep       Date:  2020-04-30       Impact factor: 8.807

5.  Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells.

Authors:  Junji Xing; Ao Zhang; Yong Du; Mingli Fang; Laurie J Minze; Yong-Jun Liu; Xian Chang Li; Zhiqiang Zhang
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 6.  Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities.

Authors:  Zhu Liang; Andreas Damianou; Elena Di Daniel; Benedikt M Kessler
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

Review 7.  An update on the regulatory mechanisms of NLRP3 inflammasome activation.

Authors:  Seungwha Paik; Jin Kyung Kim; Prashanta Silwal; Chihiro Sasakawa; Eun-Kyeong Jo
Journal:  Cell Mol Immunol       Date:  2021-04-13       Impact factor: 11.530

Review 8.  Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis.

Authors:  Chunteng Jiang; Santuan Xie; Guang Yang; Ningning Wang
Journal:  J Inflamm Res       Date:  2021-12-21

9.  A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis.

Authors:  Jie Zheng; Lu Yao; Yijing Zhou; Xiaoqun Gu; Can Wang; Kaifan Bao; Yang Sun; Min Hong
Journal:  Cell Death Dis       Date:  2021-09-24       Impact factor: 8.469

10.  DHX15 is required to control RNA virus-induced intestinal inflammation.

Authors:  Junji Xing; Xiaojing Zhou; Mingli Fang; Evan Zhang; Laurie J Minze; Zhiqiang Zhang
Journal:  Cell Rep       Date:  2021-06-22       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.